Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.01B | 2.78B | 5.09B | 2.57B | 2.36B |
Gross Profit | 1.04B | 880.84M | 2.22B | 1.39B | 923.33M |
EBITDA | 411.71M | 1.49B | 1.86B | 2.38B | 877.25M |
Net Income | -207.08M | 1.22B | 1.53B | 1.43B | 618.04M |
Balance Sheet | |||||
Total Assets | 58.41B | 53.47B | 49.25B | 47.19B | 42.62B |
Cash, Cash Equivalents and Short-Term Investments | 10.68B | 8.27B | 9.35B | 4.45B | 5.21B |
Total Debt | 8.07B | 7.21B | 6.01B | 7.56B | 6.40B |
Total Liabilities | 30.25B | 24.51B | 21.74B | 18.98B | 15.65B |
Stockholders Equity | 26.39B | 27.22B | 26.88B | 27.60B | 25.66B |
Cash Flow | |||||
Free Cash Flow | 4.03B | 1.82B | 7.67B | 654.45M | -46.99M |
Operating Cash Flow | 4.23B | 1.96B | 7.69B | 709.51M | 12.31M |
Investing Cash Flow | -186.13M | 353.31M | -1.01B | -1.68B | 642.19M |
Financing Cash Flow | -1.38B | 761.90M | -1.45B | 232.67M | 928.68M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
63 Neutral | $7.01B | 18.75 | -1.93% | 6.79% | 4.65% | -25.39% | |
47 Neutral | $6.58B | 9.14 | -0.77% | 2.21% | 8.27% | -117.00% | |
― | $785.58M | ― | -26.83% | 3.35% | ― | ― | |
― | $855.47M | 17.63 | 0.81% | 4.69% | ― | ― | |
― | $778.85M | 25.48 | 0.53% | 1.57% | ― | ― | |
― | $1.17B | ― | -4.50% | 13.18% | ― | ― | |
64 Neutral | HK$7.05B | 6.81 | 3.05% | 7.07% | -20.27% | -59.83% |
Tian An China Investments Co has announced a delay in the dispatch of a circular related to major transactions involving the formation of a joint venture and the provision of shareholder loans. The company has received a waiver from the Stock Exchange for an extension to finalize the necessary information, with the new dispatch date expected on or before July 24, 2025. This delay may impact the company’s timeline for these transactions, potentially affecting its operational plans and stakeholder expectations.
Tian An China Investments Co (TACI) has announced a major transaction involving the provision of shareholder loans. The company, through its subsidiary Greatway (Shenzhen), has entered into agreements to increase the principal amount of a shareholder loan to Xianghe Min-Hoong and extend its repayment date. This move is part of a broader financial strategy involving its joint ventures and subsidiaries. The transaction is significant enough to require shareholder approval under Hong Kong’s Listing Rules, which has been obtained through written consent from major shareholders, bypassing the need for a general meeting.
Tian An China Investments Co (TACI) has entered into a joint venture agreement through its subsidiary, Shanghai Xinfuli, to participate in a tender for a 50% equity interest in a project company that holds land use rights. This transaction, involving a major investment, has been approved by the shareholders of both TACI and its parent company, Allied Group Limited (AGL), without the need for a general meeting, as per the listing rules. The transaction is expected to impact TACI’s market positioning by expanding its asset base and potential development opportunities.
Tian An China Investments Company Limited held its Annual General Meeting on May 21, 2025, where all proposed resolutions were passed by shareholders. The resolutions included the adoption of financial statements, re-election of directors, re-appointment of auditors, and granting mandates to issue and repurchase securities. The meeting saw high approval rates for all resolutions, indicating strong shareholder support for the company’s current management and strategic direction.
Tian An China Investments Company Limited has announced its upcoming Annual General Meeting to be held on May 21, 2025, in Hong Kong. The meeting will cover several key agenda items, including the adoption of the audited financial statements for the year ending December 31, 2024, the re-election of directors, and the re-appointment of Deloitte Touche Tohmatsu as auditors. Additionally, the company will seek approval for resolutions that authorize the directors to allot and issue shares or securities convertible into shares, with certain limitations, during the specified relevant period.